Find the Perfect Plan for Your Investment Journey
B
Last Price
52 Week Range
CA$1.29 - CA$108.00
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | CA$307.54M |
EV | CA$249.83M |
Shares Outstanding | 7.65M |
Beta | 1.02 |
Analyst Rating | BUY |
Analyst Target Price | CA$80.00 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | 42.10% |
Operating Cash Flow | 36.80% |
Free Cash Flow | 43.80% |
Revenue | - |
EPS | -96.20% |
Operating Cash Flow | -269.70% |
Free Cash Flow | -501.80% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -46.18% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Bright Minds Biosciences Inc.
DRUG
Sector
Healthcare
Industry
Biotechnology
CEO
McDonald, Ian
Employees
Website
brightmindsbio.comIPO Date
2021-02-09
Headquarters
19 Vestry Street, New York, New York, 10013, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved